HIMSS 2016: Focus on Alert Fatigue
The Healthcare Information and Management Systems Society (HIMSS) is hosting its annual conference and exhibition Feb. 29-March 4, 2016, in Las Vegas. Of all the important discussions and information on emerging healthcare technologies that will be shared at the event, one of the most pressing issues is how to combat alert fatigue.
Alert fatigue is one of the top concerns for hospitals and other healthcare organizations that employ computerized order entry. Without any filtering, EMRs and e-prescribing systems fire tons of alerts for every prescription order placed. As clinicians become overwhelmed by this crushing volume of warnings — many of them for minor issues, technicalities, and scenarios the clinician has already considered — they simply begin to ignore the alerts.
But by dismissing this glut of nuisance alerts, clinicians run the very real risk of missing a relevant, important alert that could help them improve medication safety, enhance patient care, or even save a life!
See Alert Management Successes at HIMSS
Wolters Kluwer Clinical Drug Information joined forces with some of our Medi-Span drug data clients, collaborating on two presentations for HIMSS 16 — both related to how healthcare organizations used Medi-Span filter settings and standard EMR tools to better manage alerts, helping reduce noise and the fatigue that comes with unwanted alerts, while simultaneously enhancing medication safety and clinical decision support.
If you’re going to be at the conference in Vegas, don’t miss these events:
Alert Fatigue: Improving Alert Impact by Reducing Noise
- WHEN: Wednesday, March 2, 4-5 p.m. PT
- WHO: Michael Ochowski, RPh, and Phillip Boll, Group Health Cooperative South Central Wisconsin
Group Health Cooperative South Central Wisconsin leveraged the functionality of its Medi-Span drug data solution from Wolters Kluwer Clinical Drug Information to help fight alert fatigue without sacrificing the valuable clinical notifications its professionals need. Working with Medi-Span to filter alerts based on clinical metrics and input of clinician staff, Group Health Cooperative was able to reduce nuisance alerts and significantly lessen the number of clinician overrides of alerts.
- Analyze existing CPOE and pharmacy alert data to determine which are being overridden most frequently and by whom
- Establish an alert significance score based on alert severity level and quality of supporting evidence
- Use scoring to determine appropriate alert filter levels for different users (physician and pharmacist) to balance alert frequency with patient safety
- Evaluate the effectiveness of clinician satisfaction with alert filtering
Optimizing Drug Dose Checking to Minimize Alert Fatigue
- WHEN: Friday, March 4, noon-1 p.m. PT
- WHO: David Kaelbar, MD, PhD, MPH, The MetroHealth System, Cleveland, Ohio
MetroHealth used the functionality of its Medi-Span drug data solution from Wolters Kluwer Clinical Drug Information to optimize the sensitivity and specificity of clinical decision support alerts related to drug dosing. This resulted in a notable improvement in the health system’s ability to prevent clinically significant errors from occurring within the millions of prescriptions its physicians order annually.
- Define the opportunities and challenges of drug-dose checking
- Design a strategic approach to effective implementation of drug-dose checking
- Identify specific ways to optimize drug-dose checking
Is alert fatigue a problem at your organization?
Come visit us at HIMSS booth 5537 and tell us about your alert wish list. We can share more about how we help healthcare organizations reduce alert fatigue and better manage and optimize medication-related alerts.
Share your thoughts on alert fatigue and our HIMSS presentations with us on Twitter @WKDrugInfo and tag it #CDIfightsfatigue.
Want to learn more about this topic? Check out these RxPerts Academy features on alert fatigue:
You may also like:
After reviewing a large number of published clinical studies on the use of various forms of cannabis (marijuana) to treat neuropathic pain, the authors of a recent study concluded that there was limited evidence to suggest any ben...
Recently announced research from Aarhaus University in Denmark may be the first step in making key improvements to cholesterol-lowering medications. As detailed in the World Pharma News story
Stay in the Know
Sign up to start receiving notifications via email of our upcoming webinars!